CoChat

Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis

Open access
Erdmann, Anke, Rehmann-Sutter, Christoph, Bozzaro, Claudia · 2021 · BMC Medical Ethics

The DOI matches its Crossref record; 128 of the 130 references it cites were found in a registry or an index; 105 of the 236 sources its claims cite were checked for support.

Abstract

Background Precision medicine development is driven by the possibilities of next generation sequencing, information technology and artificial intelligence and thus, raises a number of ethical questions.

Overview

CoChat Summary

TL;DR

This mixed research synthesis of 92 empirical studies finds that patients and professionals generally expect high benefits from precision medicine but share ethical concerns about evidence, informed consent, access, data misuse, discrimination, incidental findings, the doctor-patient relationship, and pressure to self-optimize. It concludes that justice, autonomy, nonmaleficence, and further research on cost-effectiveness and quality of life require more attention.

Key findings

  • The review included 92 publications: 62 studies investigated professionals’ perceptions and 45 reported patients’ views; 13 ethically relevant topics were identified and mapped to Beauchamp and Childress’ principles of beneficence, nonmaleficence, autonomy, and justice.
  • Commonly perceived risks included lack of evidence for test accuracy and treatment efficacy; limited patient knowledge complicating informed consent; possible unavailability of access for underprivileged people and ethnic minorities; misuse of data by insurance companies and employers; racial stigmatization from genetic information; unwanted incidental findings; changes in the doctor-patient relationship through focusing on data; and pressure on patients to optimize their health.
  • Reported numbers include: 85% of patients felt well informed after their doctor’s explanation versus 23% of doctors agreeing patients were well informed; 84.8% of Korean participants (n = 542) were concerned PM would increase public health disparity; 27.8% of Saudi physicians (n = 126) doubted easy patient access; 78% of US patients, HCPs, and patient representatives (n = 72) were concerned about difficulty helping patients gain access; only 38.5% of US doctors (n = 104) believed PM was available to all ethnic groups; and 82.5% of 126 South Arabian physicians had poor knowledge of PM in diabetes management.
  • Patients and professionals were generally positive about PM, and patients showed high willingness to donate data and biospecimens, though fewer supported smartphone apps for lifestyle tracking; concerns included high costs, insurance coverage, and compensation if pharmaceutical companies profit from patient donations.

Methods

  • Mixed Research Synthesis integrating quantitative and qualitative studies, mainly using a qualitizing approach; a systematic search in five databases yielded 1004 records, reduced to 665 after duplicates, then 141 full-texts screened, 49 excluded, and 92 publications included.
  • Inclusion criteria covered empirical studies and reviews on patients’ and professionals’ expectations, concerns, values, and attitudes toward PM; patients were people with diseases or disabilities or patient-organization representatives, and professionals were physicians, other HCPs, and researchers; languages were German and English, with no year limit and worldwide origin.
  • Data were extracted into a spreadsheet, themes were identified and assigned to 13 topics related to Beauchamp and Childress’ four principles, and findings were summarized and discussed iteratively.

Limitations

  • Stated: the search strategy was limited to three title terms—precision medicine, personalized medicine, and genomic medicine—omitting individualized medicine and systems medicine, which likely missed relevant studies.
  • Stated: screening and eligibility assessment were performed by only one researcher; a second person would have increased reliability.
  • Evident in the text: included studies are heavily concentrated in oncology, which may limit the generalizability of the synthesized perspectives to other medical fields.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12910-021-00682-8

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Review process
Fig. 1 Review processCC BY · PubMed Central
Fig. 2 Methodology of included studies
Fig. 2 Methodology of included studiesCC BY · PubMed Central

Verification

Claims the paper makes

67 Valid · 5 Not valid · 47 Not checked · 38 Own results and interpretations

55 more claims · 24 with their cited sources checked

Create a free account to see all 157 claims and to verify the 45 references still open.

See all claims — free account
  • Probably not a substantial claim. 70
  • It may state two separate claims as one. 46

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 128 references

Research works printed but not linked: 6

  1. Maio G. Chancen und Grenzen der personalisierten Medizin - eine ethische Betrachtung. Gesundheit und Gesellschaft - Wissenschaft. 2012;12(1):15–9.
  2. Sen A. The idea of justice. London: Penguin; 2010.
  3. Maio G. Mittelpunkt Mensch: Ethik in der Medizin. Frankfurt am Main: Schattauer; 2012.
  4. Miller AM, Garfield S, Woodman RC. Patient and provider readiness for personalized medicine. Pers Med Oncol. 2016;5(4):158–67.
  5. Sommer M, Nielsen MM, Vesteghem C, Bogsted M, Dybkjaer K, Johnsen HE, et al. Hämatological cancer patients’ position on precision medicine—a questionnaire survey. Basic Clin Pharmacol Toxicol. 2018;123:4.
  6. Kraft SA, Cho MK, Gillespie K. Beyond consent: building trusting relationships with diverse populations in precision medicine research. Am J Bioeth. 2018;18(4):3–20. · DOI · Paper page

Cited by

See all 86

Metadata

Authors
Erdmann, A., Rehmann-Sutter, C., & Bozzaro, C.
Affiliations
Christian-Albrechts-Universität zu Kiel (DE)
Corresponding author
Erdmann, Anke
Venue
BMC Medical Ethics
Published
2021-08-31
Volume
22
Issue
1
Pages
116-116
ISSN
1472-6939 (ISSN-L)
OpenAlex
W3197057224
Cited by
86
References
130
Citations by year
2026: 12 · 2025: 26 · 2024: 22 · 2023: 14 · 2022: 9 · 2021: 3
FWCI
2.14
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medical Ethics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (F381 434.)
  • Universitätsklinikum Schleswig-Holstein - Campus Kiel
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Social Sciences › Law › Medical and Health Sciences Research
Keywords
precision medicine, bioethics, patient attitudes, healthcare professionals' perspectives, informed consent, incidental finding, genetic discrimination, justice, autonomy, data security, physician-patient relationship, cost-effectiveness, genetic testing
MeSH terms
Artificial Intelligence, Humans, Informed Consent, Physician-Patient Relations, Quality of Life, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis. https://app.cochat.ai/papers/10.1186/s12910-021-00682-8
The paper
Erdmann, A., Rehmann-Sutter, C., & Bozzaro, C. (2021). Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis. BMC Medical Ethics. https://doi.org/10.1186/s12910-021-00682-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.